News

Provigate and Sysmex has entered into a basic agreement for joint development of POCT for glycated albumin

Provigate partnered with Japanese clinical testing giant H.U. to develop an innovative blood glucose monitoring service.

An interview with Dr. Sekimizu, CEO of Provigate, entitled ‘New method for diabetes care with breaking through glucose monitoring’, was published in Toyo Keizai ONLINE. (In Japanese)

An interview with Provigate CEO Sekimizu, ‘New tools for diabetes care by ‘accidental entrepreneurs”, was published on the University of Tokyo website.

The interview “How will technology face the ageing society?” with Dr Sekimizu, CEO of Provigate, was published online in note of ANRI, one of the main shareholders of Provigate.(In Japanese)

Interview with Dr Sekimizu, CEO of Provigate, on Newswitch, “Solving the challenges of blood glucose management for people with diabetes” was published online. (In Japanese)

INITIAL published online an interview with Dr Sekimizu, CEO of Provigate, entitled ‘Deep tech Provigate pivots to the world in a wake-up call’. (In Japanese)

Interview with Dr Sekimizu, CEO of Provigate, ‘Blood glucose sensors that integrate into daily life to prevent the onset and severity of diabetes’, was published in the July 2021 issue of JSTnews. (In Japanese)

Provigate was introduced in the special feature ‘Medical Tech Ventures’ in the Weekly Toyo Keizai. (In Japanese)

‘An interview with Provigate’s external director, Yasunori Kaneko, a pioneering Japanese venture capitalist (4)’ was published online in Nikkei Biotech. (In Japanese)